CVS Health CorporationCVSNYSE
Loading
EBITDA Over TimeContracting
Percentile Rank21
3Y CAGR-7.2%
5Y CAGR-10.4%
Year-over-Year Change
Earnings before interest, taxes, depreciation, and amortization
3Y CAGR
-7.2%/yr
vs +16.3%/yr prior
5Y CAGR
-10.4%/yr
Recent acceleration
Acceleration
-23.5pp
Decelerating
Percentile
P21
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $9.86B | -27.9% |
| 2024 | $13.68B | -24.8% |
| 2023 | $18.20B | +47.4% |
| 2022 | $12.35B | -29.6% |
| 2021 | $17.53B | +2.4% |
| 2020 | $17.12B | +4.4% |
| 2019 | $16.40B | +143.3% |
| 2018 | $6.74B | -42.9% |
| 2017 | $11.81B | -3.1% |
| 2016 | $12.19B | - |